| WT |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
10% |
100 |
β |
56 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| WT |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
20% |
100 |
β |
27 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| WT |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
30% |
100 |
β |
13 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| WT |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
40% |
100 |
β |
5 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| WT |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
50% |
100 |
β |
3 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| WT |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
20% |
100 |
β |
19 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| WT |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
n-Octane |
100% |
100 |
β |
18 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| WT |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
n-Hexane |
100% |
100 |
β |
13 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| WT |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Toluene |
100% |
100 |
β |
19 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| WT |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Butyl Acetate |
100% |
100 |
β |
21 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| WT |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Acetonitrile |
100% |
100 |
β |
6 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| WT |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethylformamide (DMF) |
100% |
100 |
β |
2 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| WT |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
100% |
100 |
β |
2 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| WT |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
30% |
100 |
β |
5 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| WT |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
40% |
100 |
β |
3 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| WT |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
50% |
100 |
β |
2 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| WT |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
10% |
100 |
β |
50 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| D168E/A234S/A235V/L263Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
50% |
100 |
3 |
57 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| V34A/L292Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
50% |
100 |
3 |
23 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| V34A/L292Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
40% |
100 |
5 |
38 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| V34A/L292Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
30% |
100 |
13 |
48 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| V34A/L292Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
20% |
100 |
27 |
54 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| V34A/L292Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
10% |
100 |
56 |
74 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| D168E/A234S/A235V/L263Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
20% |
100 |
27 |
76 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| D168E/A234S/A235V/L263Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
40% |
100 |
5 |
60 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| D168E/A234S/A235V/L263Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
30% |
100 |
13 |
70 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| Y251F/L263Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
10% |
100 |
56 |
83 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| Y251F/L263Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
20% |
100 |
27 |
68 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| Y251F/L263Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
30% |
100 |
13 |
60 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| Y251F/L263Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
40% |
100 |
5 |
52 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| Y251F/L263Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
50% |
100 |
3 |
36 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| D168E/A234S/A235V/L263Q |
Activity - Classical |
Activity measured by TLC-FID in the presence of organic solvent |
Dimethyl Sulfoxide (DMSO) |
10% |
100 |
56 |
94 |
% |
50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
9 |
40Β°C |
20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" |
Classical aqueous control (in %) |
| D168E/A234S/A235V/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
40% |
100 |
3 |
39 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| Y251F/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethylformamide (DMF) |
100% |
100 |
2 |
15 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| Y251F/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
100% |
100 |
2 |
27 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| V34A/L292Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
50% |
100 |
2 |
25 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| V34A/L292Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
40% |
100 |
3 |
29 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| V34A/L292Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
30% |
100 |
5 |
39 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| V34A/L292Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
20% |
100 |
19 |
52 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| V34A/L292Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
10% |
100 |
50 |
78 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| D168E/A234S/A235V/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
50% |
100 |
2 |
37 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| Y251F/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Acetonitrile |
100% |
100 |
6 |
30 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| D168E/A234S/A235V/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
30% |
100 |
5 |
46 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| D168E/A234S/A235V/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
20% |
100 |
19 |
57 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| D168E/A234S/A235V/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
10% |
100 |
50 |
86 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| Y251F/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
50% |
100 |
2 |
28 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| Y251F/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
40% |
100 |
3 |
30 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| Y251F/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
30% |
100 |
5 |
41 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| Y251F/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
20% |
100 |
19 |
61 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| Y251F/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
10% |
100 |
50 |
84 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| V34A/L292Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
100% |
100 |
2 |
26 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| Y251F/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
n-Octane |
100% |
100 |
18 |
64 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| D168E/A234S/A235V/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethyl Sulfoxide (DMSO) |
100% |
100 |
2 |
38 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| D168E/A234S/A235V/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethylformamide (DMF) |
100% |
100 |
2 |
21 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| D168E/A234S/A235V/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Acetonitrile |
100% |
100 |
6 |
35 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| D168E/A234S/A235V/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Butyl Acetate |
100% |
100 |
21 |
78 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| D168E/A234S/A235V/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Toluene |
100% |
100 |
19 |
64 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| D168E/A234S/A235V/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
n-Hexane |
100% |
100 |
13 |
58 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| D168E/A234S/A235V/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
n-Octane |
100% |
100 |
18 |
81 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| Y251F/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
n-Hexane |
100% |
100 |
13 |
42 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| V34A/L292Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Dimethylformamide (DMF) |
100% |
100 |
2 |
16 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| V34A/L292Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Acetonitrile |
100% |
100 |
6 |
30 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| V34A/L292Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Butyl Acetate |
100% |
100 |
21 |
70 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| V34A/L292Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Toluene |
100% |
100 |
19 |
32 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| V34A/L292Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
n-Hexane |
100% |
100 |
13 |
36 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| V34A/L292Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
n-Octane |
100% |
100 |
18 |
70 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| Y251F/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Toluene |
100% |
100 |
19 |
52 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |
| Y251F/L263Q |
Stability - Incubation |
Activity after incubation (10 hours at 37Β°C), measured by measuring product concentration by TLC-FID in aqueous phase |
Butyl Acetate |
100% |
100 |
21 |
72 |
% |
Incubation: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS, Assay: 50 mM Tris-HCl, 10 mM CaCl2, 450 Β΅M CHAPS |
Incubation: 9, Assay: 9 |
Incubation: 37Β°C, Assay: 40Β°C |
2 mL of 20 Β΅M 1,2-dimyristoyl-sn-glycero-3-phosphocholine |
2-myristoyl-lysophosphatidylcholine, Myristic acid |
β |
Yes, "thorough shaking" assay |
Non-incubated control (in %), assay in aqueous phase |